Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.

Company Growth (employees)
Utrecht, NL
Size (employees)
55 (est)+2%
Merus was founded in 2003 and is headquartered in Utrecht, NL

Merus Office Locations

Merus has an office in Utrecht
Utrecht, NL (HQ)
H.R. Kruytgebouw 8 Padualaan

Merus Metrics

Summary Metrics

Merus's latest funding round in April 2015 was reported to be $79.1 m. In total, Merus has raised $149.3 m

Merus News

Merus Company Life

You may also be interested in